Novartis Ag (NVS) Acquisitions (2009 - 2025)
Novartis Ag (NVS) posted Acquisitions of -$21.0 million for Q4 2025, down 2200.0% sequentially from $1.0 million in Q3 2025, and up 95.07% YoY from -$10.8 million in Q4 2024.
Novartis Ag (NVS) Acquisitions (2009 - 2025) Analysis & Trends
Novartis Ag (NVS) has 6 years of Acquisitions data on file, last reported at -$21.0 million in Q4 2025.
- Quarterly Acquisitions rose 95.07% year-over-year to -$21.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$504.0 million (down 4.13% YoY) and the FY2025 annual result came in at -$147.0 million, up 96.24% from the prior year.
- Acquisitions declined to -$21.0 million in Q4 2025 per NVS's latest filing, from $1.0 million in the prior quarter.
- The five-year high for Acquisitions was $1.0 million in Q3 2025, with the low at -$426.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 7.56 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 8.78 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 109.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -21.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Dec 31, 2024 | -426.00 Mn |
| Sep 30, 2024 | -58.00 Mn |
| Dec 31, 2015 | -135.00 |
| Sep 30, 2015 | -228.00 |
| Jun 30, 2015 | -124.00 |
| Dec 31, 2014 | -350.00 |
| Sep 30, 2014 | -2.00 |
| Jun 30, 2014 | 114.00 |
| Mar 31, 2014 | -93.00 |
| Dec 31, 2013 | -32.00 |
| Sep 30, 2013 | -10.00 |
| Jun 30, 2013 | -32.00 |
| Dec 31, 2012 | -183.00 |
| Mar 31, 2011 | -589.00 |
| Dec 31, 2009 | -35.00 |